BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25936600)

  • 1. High expression of PKM2 as a poor prognosis indicator is associated with radiation resistance in cervical cancer.
    Zhao Y; Shen L; Chen X; Qian Y; Zhou Q; Wang Y; Li K; Liu M; Zhang S; Huang X
    Histol Histopathol; 2015 Nov; 30(11):1313-20. PubMed ID: 25936600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HK2 is a radiation resistant and independent negative prognostic factor for patients with locally advanced cervical squamous cell carcinoma.
    Huang X; Liu M; Sun H; Wang F; Xie X; Chen X; Su J; He Y; Dai Y; Wu H; Shen L
    Int J Clin Exp Pathol; 2015; 8(4):4054-63. PubMed ID: 26097593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
    Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.
    Huang XQ; Chen X; Xie XX; Zhou Q; Li K; Li S; Shen LF; Su J
    Int J Clin Exp Pathol; 2014; 7(4):1651-66. PubMed ID: 24817962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
    Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
    Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of TRAIL signalling molecules in cervical squamous cell carcinoma.
    Yao Q; Du J; Lin J; Luo Y; Wang Y; Liu Y; Zhang B; Ren C; Liu C
    J Clin Pathol; 2016 Feb; 69(2):122-7. PubMed ID: 26254281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of osteopontin and E-cadherin indicates radiation resistance and poor prognosis for patients with cervical carcinoma.
    Huang X; Qian Y; Wu H; Xie X; Zhou Q; Wang Y; Kuang W; Shen L; Li K; Su J; Shen L; Chen X
    J Histochem Cytochem; 2015 Feb; 63(2):88-98. PubMed ID: 25380749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of Kruppel-like factor 4 as a predictor of poor prognosis for cervical cancer patient response to radiotherapy.
    Liu HX; Li N; Wei L; Zhou FX; Ma R; Xiao F; Zhang W; Zhang Y; Hui YP; Song H; Chen BL
    Tumour Biol; 2017 Jun; 39(6):1010428317710225. PubMed ID: 28639905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
    Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear PKM2 expression, an independent risk factor for ER after curative resection of hepatocellular carcinoma.
    Fan F; Wu H; Liu Z; Hou X; Chen W; Wang A; Lu Y
    Biomed Pharmacother; 2016 Dec; 84():1858-1864. PubMed ID: 27894667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
    Zhang Y; Yan M; He J; Sun J; Sun X
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stomatin-like protein 2 expression is associated with clinical survival in patients with cervical cancer.
    Xiao B; Xie Z; Guo L; Wu J; Zhang H
    Int J Clin Exp Pathol; 2015; 8(2):1804-9. PubMed ID: 25973071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of clinical efficacy of intensity-modulated radiation therapy and the prognosis factors in advanced cervical cancer].
    Gao K; Ding L; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):30-5. PubMed ID: 24694915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-1 is an independent prognostic factor for local recurrence and survival after definitive radiation therapy for patients with squamous cell carcinoma of the uterine cervix.
    Huang EY; Chanchien CC; Lin H; Wang CC; Wang CJ; Huang CC
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):975-82. PubMed ID: 24139517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy for stage IVA cervical cancer.
    Murakami N; Kasamatsu T; Morota M; Sumi M; Inaba K; Ito Y; Itami J
    Anticancer Res; 2013 Nov; 33(11):4989-94. PubMed ID: 24222140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma.
    Moreno-Acosta P; Vallard A; Carrillo S; Gamboa O; Romero-Rojas A; Molano M; Acosta J; Mayorga D; Rancoule C; Garcia MA; Cotes Mestre M; Magné N
    Radiat Oncol; 2017 Jul; 12(1):120. PubMed ID: 28716107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma.
    Guo CY; Zhu Q; Tou FF; Wen XM; Kuang YK; Hu H
    BMC Cancer; 2019 Mar; 19(1):289. PubMed ID: 30925904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
    Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
    Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
    Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
    Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.